Clinical Trial Update: Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating topotecan plus sargramostim in adults with advanced cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Topotecan (topotecan)
• sargramostim (sargramostim)

Snippet

Sponsor: Yale University | Conditions: Unspecified Adult Solid Tumor, Protocol Specific | Phase 1, Phase 2 | Status: COMPLETED